ZALEPLON (zaleplon) by Molecular Devices is clinical pharmacology pharmacodynamics and mechanism of action while zaleplon is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (gaba-bz) receptor complex. Approved for gamma-aminobutyric acid a receptor agonist [epc]. First approved in 2008.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Pharmacodynamics and Mechanism of Action While zaleplon is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABA-BZ) receptor…
Worked on ZALEPLON at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Zaleplon 10mg Capsules Under Fasting Conditions
Zaleplon 10 mg Capsules Under Non-Fasting Conditions